BioCentury
ARTICLE | Financial News

Knight Therapeutics completes private placement of warrants

March 24, 2014 7:00 AM UTC

Knight President and CEO Jonathan Goodman purchased 6.1 million warrants, or about C$21.2 million ($19.1 million) in the offering. Knight is owned by the former Paladin Labs Inc. shareholders and was...